Portal Diabetes Gets FDA Breakthrough for Pump, Starts Insulin Study

Portal Diabetes’ insulin pump receives FDA breakthrough device designation

Portal Diabetes has received the US FDA breakthrough device designation for its implantable insulin pump system, known as the Portal Pump.The post Portal Diabetes’ insulin pump receives FDA breakthrough device designation  appeared first on Medical Device Network.

Portal earns FDA breakthrough nod for implantable insulin pump

The Portal Pump, an implantable system for closed-loop insulin delivery. [Image from Portal Diabetes]Portal Diabetes announced today that it received FDA breakthrough device designation for its implantable insulin pump system. The Westfield, Indiana-based company can now begin a Phase 1 study to evaluate its proprietary, temperature-stable insulin. It aims to deliver a functional cure for type 1 diabetes. Portal Diabetes developed its system, ca…

Portal Diabetes Gets FDA Breakthrough for Pump, Starts Insulin Study

Today, Portal Diabetes, Inc. ("Portal") announced its receipt of the Breakthrough Device Designation by the Food and Drug Administration (FDA) for its implantable insulin pump system called "Portal Pump," and the start of a Phase 1 study on its proprietary temperature-stable insulin ("Portal Insulin").